Earnings History Data for CorMedix Inc. (CRMD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CorMedix Inc.

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. Defencath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product, which provides an additional five years of marketing exclusivity, which will be added to the five years granted to a New Chemical Entity upon approval of the NDA. CorMedix also intends to develop Defencath as a catheter lock solution for use in oncology and total parenteral nutrition patients. It is leveraging its taurolidine technology to develop a pipeline of antimicrobial medical devices, with programs in surgical sutures and meshes, and topical hydrog
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-03-2024 PM CRMD CorMedix Inc. 201.71 -0.26 -0.21 -0.20 CorMedix GAAP EPS of -$0.26 misses by $0.06
[3/12/2024 7:31 AM]
3.42 -0.10 
(-2.70%)
3.37 -0.15 
(-4.26%)
2.57 - 6.09 1,172,398 350,000 6,743
14-11-2023 AH CRMD CorMedix Inc. 176.47 -0.17 -0.21 -0.17 CorMedix GAAP EPS of -$0.17 beats by $0.04
[11/14/2023 4:10 PM]
3.35 0.22 
(6.96%)
3.69 0.56 
(17.89%)
2.57 - 6.09 13,013,495 770,000 510,007
08-08-2023 PM CRMD CorMedix Inc. 193.31 -0.25 -0.22 -0.19 CorMedix GAAP EPS of -$0.25 misses by $0.01
[8/8/2023 7:33 AM]
4.42 0.32 
(7.81%)
4.10 0.0 
(0.00%)
2.71 - 8.02 614,193 600,000 202
15-05-2023 AH After the close
(May 15)
CRMD CorMedix Inc. 236.29 -0.24 -0.20 -0.18 CorMedix GAAP EPS of -$0.24 misses by $0.04
[5/15/2023 4:12 PM]
4.49 -0.66 
(-12.82%)
5.20 0.05 
(0.89%)
2.64 - 8.02 851,019 260,000 11,953
30-03-2023 PM 7:30 AM ET
(Mar 30)
CRMD CorMedix Inc. 161.00 -0.20 -0.19 -0.20 CorMedix GAAP EPS of -$0.20 misses by $0.01, revenue of $0.03M beats by $0.03M
[3/30/2023 7:32 AM]
4.14 0.48 
(13.11%)
3.85 0.19 
(5.19%)
2.64 - 8.02 524,369 170,000 31,280
10-11-2022 PM 7:30 AM ET
(Nov 10)
CRMD CorMedix Inc. 123.62 -0.17 -0.23 -0.22 CorMedix GAAP EPS of -$0.17 beats by $0.06, revenue of $6.82M
[11/10/2022 7:36 AM]
3.09 0.26 
(9.19%)
3.07 0.24 
(8.48%)
2.64 - 8.02 326,124 150,000 21,079
11-08-2022 PM 0:00 AM ET
(Aug 11)
CRMD CorMedix Inc. 212.05 -0.19 -0.20 -0.12 CorMedix GAAP EPS of -$0.19 beats by $0.02, revenue of $0.02M
[8/11/2022 8:02 AM]
3.72 0.34 
(10.09%)
3.26 -0.12 
(-3.55%)
2.65 - 8.03 1,394,093 1,140,000 65,116
12-05-2022 AH 4:00 PM ET
(May 12)
CRMD CorMedix Inc. 130.90 -0.18 -0.23 -0.20 CorMedix GAAP EPS of -$0.18 beats by $0.04, revenue of $0.01M misses by $0.01M
[5/12/2022 4:05 PM]
3.27 0.29 
(9.73%)
3.20 0.22 
(7.38%)
2.87 - 8.38 257,292 310,000 3,705
29-03-2022 AH 4:05 PM ET
(Mar 29)
CRMD CorMedix Inc. 230.80 -0.20 -0.22 -0.19 CorMedix GAAP EPS of -$0.20 beats by $0.03, revenue of $0.06M beats by $0.05M
[3/29/2022 4:06 PM]
5.83 0.29 
(5.23%)
5.80 0.26 
(4.69%)
3.65 - 10.40 847,902 460,000 2,336
09-11-2021 AH 4:00 PM ET
(Nov 9)
CRMD CorMedix Inc. 200.33 -0.22 -0.18 -0.22 CorMedix EPS misses by $0.04, beats on revenue
[11/9/2021 4:13 PM]
5.29 0.06 
(1.15%)
5.05 -0.18 
(-3.44%)
4.36 - 18.80 316,152 290,000 5,518
12-08-2021 AH 4:00 PM ET
(Aug 12)
CRMD CorMedix Inc. 228.70 -0.12 -0.18 -0.14 CorMedix EPS beats by $0.06, misses on revenue
[8/12/2021 4:10 PM]
6.35 0.40 
(6.72%)
6.01 0.06 
(1.01%)
3.86 - 18.80 394,314 210,000 953
13-05-2021 AH 4:05 PM ET
(May 13)
CRMD CorMedix Inc. 323.59 -0.20 -0.18 -0.21 CorMedix EPS misses by $0.02, beats on revenue
[5/13/2021 4:23 PM]
6.01 -1.55 
(-20.50%)
5.57 -1.99 
(-26.32%)
3.64 - 18.80 2,881,406 310,000 171,968
30-03-2021 AH 4:05 PM ET
(Mar 30)
CRMD CorMedix Inc. 274.73 -0.19 -0.23 -0.21 CorMedix EPS beats by $0.03, beats on revenue
[3/30/2021 4:07 PM]
10.00 1.01 
(11.23%)
8.70 -0.29 
(-3.23%)
3.00 - 18.80 923,816 590,000 2,685
05-11-2020 AH 4:05 PM ET
(Nov 5)
CRMD CorMedix Inc. 169.00 -0.22 -0.26 -0.22 CorMedix EPS beats by $0.04, beats on revenue
[11/5/2020 5:55 PM]
5.28 -0.10 
(-1.86%)
5.04 -0.34 
(-6.32%)
2.16 - 7.97 182,791 209,640 13,381
10-08-2020 AH 4:10 PM ET
(Aug 10)
CRMD CorMedix Inc. 114.44 -0.14 -0.24 -0.24 CorMedix EPS in-line, misses on revenue
[8/10/2020 4:28 PM]
4.19 -0.06 
(-1.41%)
4.20 -0.05 
(-1.18%)
2.16 - 8.64 253,833 749,293 1,662